Bio-Path Holdings, Inc. (BPTH)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Bio-Path Holdings, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Bio-Path Holdings, Inc. (BPTH) has returned -0.00% so far this year and -64.69% over the past 12 months. Over the last ten years, BPTH has returned -70.18% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.

Based on dividend-adjusted daily data since Mar 4, 2008, BPTH's average daily return is +0.18%, while the average monthly return is +1.61%. At this rate, your investment would double in approximately 3.6 years.

Historically, 40% of months were positive and 60% were negative. The best month was Mar 2019 with a return of +684.2%, while the worst month was Feb 2025 at -77.7%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 13 months.

On a daily basis, BPTH closed higher 38% of trading days. The best single day was Mar 7, 2019 with a return of +223.3%, while the worst single day was Feb 18, 2025 at -66.8%.

Bio-Path Holdings, Inc. has an annualized alpha of 50.78%, beta of 0.43, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since March 05, 2008.

• This stock participated in 197.94% of S&P 500 Index downside but only -31.94% of its upside — more exposed to losses than it benefited from rallies.
• Beta of 0.43 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

BPTH ranks 21 for risk / return — below 21% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The table below present risk-adjusted performance metrics for Bio-Path Holdings, Inc. (BPTH) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Bio-Path Holdings, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Bio-Path Holdings, Inc. was 100.00%, occurring on Jan 20, 2026. The portfolio has not yet recovered.

The current Bio-Path Holdings, Inc. drawdown is 100.00%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Bio-Path Holdings, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Bio-Path Holdings, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.